APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

IVD Reagent Clinical Trial Services

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global IVD Reagent Clinical Trial Services Industry Growth and Trends Forecast to 2032

Report ID 17417178011 May 2026123 pages

Choose your research edition.

Industry ResearchIVD Reagent Clinical Trial Services Industry Research Report 2026137 pages · $2,950 USDIndustry Growth & TrendsGlobal IVD Reagent Clinical Trial Services Industry Growth and Trends Forecast to 2032123 pages · $3,450 USDMarket StructureGlobal IVD Reagent Clinical Trial Services Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal IVD Reagent Clinical Trial Services Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal IVD Reagent Clinical Trial Services Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

According to APO Research, the global IVD Reagent Clinical Trial Services market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for IVD Reagent Clinical Trial Services is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for IVD Reagent Clinical Trial Services is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for IVD Reagent Clinical Trial Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the IVD Reagent Clinical Trial Services market include IQVIA, ICON plc, Labcorp, NAMSA, Parexel, Medpace, Fortrea, Quest Diagnostics and Avania, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global IVD Reagent Clinical Trial Services market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The IVD Reagent Clinical Trial Services market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global IVD Reagent Clinical Trial Services market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to IVD Reagent Clinical Trial Services.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global IVD Reagent Clinical Trial Services market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

IVD Reagent Clinical Trial Services Market by Company

IQVIA

ICON plc

Labcorp

NAMSA

Parexel

Medpace

Fortrea

Quest Diagnostics

Avania

Hangzhou Tigermed Consulting

Eurofins Scientific

Cerba Research

ClinChoice

CMIC Group

Syneos Health

ResearchDx

Premier Research

Quanticate

SGS

Guangzhou Jinmanli Pharmaceutical Technology

WuXi AppTec

IVD Reagent Clinical Trial Services Segment by Type

Early-Stage Clinical Trials (Phase I)

Late-Stage Clinical Trials (Phase III)

IVD Reagent Clinical Trial Services Segment by Application

Early Cancer Screening

Infectious Disease Testing

Genetic Disease Diagnosis

Other

IVD Reagent Clinical Trial Services Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global IVD Reagent Clinical Trial Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of IVD Reagent Clinical Trial Services and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of IVD Reagent Clinical Trial Services.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of IVD Reagent Clinical Trial Services companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global IVD Reagent Clinical Trial Services Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global IVD Reagent Clinical Trial Services Market Size by Region (2021-2026) & (US$ Million) Table 3. Global IVD Reagent Clinical Trial Services Market Share by Region (2021-2026) Table 4. Global IVD Reagent Clinical Trial Services Market Size by Region (2027-2032) & (US$ Million) Table 5. Global IVD Reagent Clinical Trial Services Market Share by Region (2027-2032) Table 6. Global IVD Reagent Clinical Trial Services Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global IVD Reagent Clinical Trial Services Market Size by Type (2021-2026) & (US$ Million) Table 8. Global IVD Reagent Clinical Trial Services Market Size Share by Type (2021-2026) Table 9. Global IVD Reagent Clinical Trial Services Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global IVD Reagent Clinical Trial Services Market Size Share Forecasted by Type (2027-2032) Table 11. North America IVD Reagent Clinical Trial Services Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America IVD Reagent Clinical Trial Services Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe IVD Reagent Clinical Trial Services Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe IVD Reagent Clinical Trial Services Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific IVD Reagent Clinical Trial Services Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific IVD Reagent Clinical Trial Services Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America IVD Reagent Clinical Trial Services Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America IVD Reagent Clinical Trial Services Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa IVD Reagent Clinical Trial Services Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa IVD Reagent Clinical Trial Services Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global IVD Reagent Clinical Trial Services Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global IVD Reagent Clinical Trial Services Market Size by Application (2021-2026) & (US$ Million) Table 23. Global IVD Reagent Clinical Trial Services Market Size Share by Application (2021-2026) Table 24. Global IVD Reagent Clinical Trial Services Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global IVD Reagent Clinical Trial Services Market Size Share Forecasted by Application (2027-2032) Table 26. North America IVD Reagent Clinical Trial Services Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America IVD Reagent Clinical Trial Services Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe IVD Reagent Clinical Trial Services Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe IVD Reagent Clinical Trial Services Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific IVD Reagent Clinical Trial Services Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific IVD Reagent Clinical Trial Services Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America IVD Reagent Clinical Trial Services Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America IVD Reagent Clinical Trial Services Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa IVD Reagent Clinical Trial Services Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa IVD Reagent Clinical Trial Services Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. IVD Reagent Clinical Trial Services Industry Trends Table 37. IVD Reagent Clinical Trial Services Industry Drivers Table 38. IVD Reagent Clinical Trial Services Industry Opportunities and Challenges Table 39. IVD Reagent Clinical Trial Services Industry Restraints Table 40. Global IVD Reagent Clinical Trial Services Revenue by Company (US$ Million) & (2021-2026) Table 41. Global IVD Reagent Clinical Trial Services Revenue Market Share by Company (2021-2026) Table 42. Global IVD Reagent Clinical Trial Services Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global IVD Reagent Clinical Trial Services Key Company Headquarters & Area Served Table 44. Global IVD Reagent Clinical Trial Services Company, Product Type & Application Table 45. Global IVD Reagent Clinical Trial Services Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global IVD Reagent Clinical Trial Services by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. IQVIA Company Information Table 49. IQVIA Business Overview Table 50. IQVIA IVD Reagent Clinical Trial Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. IQVIA IVD Reagent Clinical Trial Services Product Portfolio Table 52. IQVIA Recent Development Table 53. ICON plc Company Information Table 54. ICON plc Business Overview Table 55. ICON plc IVD Reagent Clinical Trial Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. ICON plc IVD Reagent Clinical Trial Services Product Portfolio Table 57. ICON plc Recent Development Table 58. Labcorp Company Information Table 59. Labcorp Business Overview Table 60. Labcorp IVD Reagent Clinical Trial Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Labcorp IVD Reagent Clinical Trial Services Product Portfolio Table 62. Labcorp Recent Development Table 63. NAMSA Company Information Table 64. NAMSA Business Overview Table 65. NAMSA IVD Reagent Clinical Trial Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. NAMSA IVD Reagent Clinical Trial Services Product Portfolio Table 67. NAMSA Recent Development Table 68. Parexel Company Information Table 69. Parexel Business Overview Table 70. Parexel IVD Reagent Clinical Trial Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Parexel IVD Reagent Clinical Trial Services Product Portfolio Table 72. Parexel Recent Development Table 73. Medpace Company Information Table 74. Medpace Business Overview Table 75. Medpace IVD Reagent Clinical Trial Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Medpace IVD Reagent Clinical Trial Services Product Portfolio Table 77. Medpace Recent Development Table 78. Fortrea Company Information Table 79. Fortrea Business Overview Table 80. Fortrea IVD Reagent Clinical Trial Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. Fortrea IVD Reagent Clinical Trial Services Product Portfolio Table 82. Fortrea Recent Development Table 83. Quest Diagnostics Company Information Table 84. Quest Diagnostics Business Overview Table 85. Quest Diagnostics IVD Reagent Clinical Trial Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Quest Diagnostics IVD Reagent Clinical Trial Services Product Portfolio Table 87. Quest Diagnostics Recent Development Table 88. Avania Company Information Table 89. Avania Business Overview Table 90. Avania IVD Reagent Clinical Trial Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. Avania IVD Reagent Clinical Trial Services Product Portfolio Table 92. Avania Recent Development Table 93. Hangzhou Tigermed Consulting Company Information Table 94. Hangzhou Tigermed Consulting Business Overview Table 95. Hangzhou Tigermed Consulting IVD Reagent Clinical Trial Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. Hangzhou Tigermed Consulting IVD Reagent Clinical Trial Services Product Portfolio Table 97. Hangzhou Tigermed Consulting Recent Development Table 98. Eurofins Scientific Company Information Table 99. Eurofins Scientific Business Overview Table 100. Eurofins Scientific IVD Reagent Clinical Trial Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. Eurofins Scientific IVD Reagent Clinical Trial Services Product Portfolio Table 102. Eurofins Scientific Recent Development Table 103. Cerba Research Company Information Table 104. Cerba Research Business Overview Table 105. Cerba Research IVD Reagent Clinical Trial Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. Cerba Research IVD Reagent Clinical Trial Services Product Portfolio Table 107. Cerba Research Recent Development Table 108. ClinChoice Company Information Table 109. ClinChoice Business Overview Table 110. ClinChoice IVD Reagent Clinical Trial Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. ClinChoice IVD Reagent Clinical Trial Services Product Portfolio Table 112. ClinChoice Recent Development Table 113. CMIC Group Company Information Table 114. CMIC Group Business Overview Table 115. CMIC Group IVD Reagent Clinical Trial Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 116. CMIC Group IVD Reagent Clinical Trial Services Product Portfolio Table 117. CMIC Group Recent Development Table 118. Syneos Health Company Information Table 119. Syneos Health Business Overview Table 120. Syneos Health IVD Reagent Clinical Trial Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 121. Syneos Health IVD Reagent Clinical Trial Services Product Portfolio Table 122. Syneos Health Recent Development Table 123. ResearchDx Company Information Table 124. ResearchDx Business Overview Table 125. ResearchDx IVD Reagent Clinical Trial Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 126. ResearchDx IVD Reagent Clinical Trial Services Product Portfolio Table 127. ResearchDx Recent Development Table 128. Premier Research Company Information Table 129. Premier Research Business Overview Table 130. Premier Research IVD Reagent Clinical Trial Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 131. Premier Research IVD Reagent Clinical Trial Services Product Portfolio Table 132. Premier Research Recent Development Table 133. Quanticate Company Information Table 134. Quanticate Business Overview Table 135. Quanticate IVD Reagent Clinical Trial Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 136. Quanticate IVD Reagent Clinical Trial Services Product Portfolio Table 137. Quanticate Recent Development Table 138. SGS Company Information Table 139. SGS Business Overview Table 140. SGS IVD Reagent Clinical Trial Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 141. SGS IVD Reagent Clinical Trial Services Product Portfolio Table 142. SGS Recent Development Table 143. Guangzhou Jinmanli Pharmaceutical Technology Company Information Table 144. Guangzhou Jinmanli Pharmaceutical Technology Business Overview Table 145. Guangzhou Jinmanli Pharmaceutical Technology IVD Reagent Clinical Trial Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 146. Guangzhou Jinmanli Pharmaceutical Technology IVD Reagent Clinical Trial Services Product Portfolio Table 147. Guangzhou Jinmanli Pharmaceutical Technology Recent Development Table 148. WuXi AppTec Company Information Table 149. WuXi AppTec Business Overview Table 150. WuXi AppTec IVD Reagent Clinical Trial Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 151. WuXi AppTec IVD Reagent Clinical Trial Services Product Portfolio Table 152. WuXi AppTec Recent Development Table 153. North America IVD Reagent Clinical Trial Services Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 154. North America IVD Reagent Clinical Trial Services Market Size by Country (2021-2026) & (US$ Million) Table 155. North America IVD Reagent Clinical Trial Services Market Share by Country (2021-2026) Table 156. North America IVD Reagent Clinical Trial Services Market Size Forecast by Country (2027-2032) & (US$ Million) Table 157. North America IVD Reagent Clinical Trial Services Market Share Forecast by Country (2027-2032) Table 158. Europe IVD Reagent Clinical Trial Services Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 159. Europe IVD Reagent Clinical Trial Services Market Size by Country (2021-2026) & (US$ Million) Table 160. Europe IVD Reagent Clinical Trial Services Market Share by Country (2021-2026) Table 161. Europe IVD Reagent Clinical Trial Services Market Size Forecast by Country (2027-2032) & (US$ Million) Table 162. Europe IVD Reagent Clinical Trial Services Market Share Forecast by Country (2027-2032) Table 163. Asia-Pacific IVD Reagent Clinical Trial Services Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 164. Asia-Pacific IVD Reagent Clinical Trial Services Market Size by Country (2021-2026) & (US$ Million) Table 165. Asia-Pacific IVD Reagent Clinical Trial Services Market Share by Country (2021-2026) Table 166. Asia-Pacific IVD Reagent Clinical Trial Services Market Size Forecast by Country (2027-2032) & (US$ Million) Table 167. Asia-Pacific IVD Reagent Clinical Trial Services Market Share Forecast by Country (2027-2032) Table 168. Latin America IVD Reagent Clinical Trial Services Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 169. Latin America IVD Reagent Clinical Trial Services Market Size by Country (2021-2026) & (US$ Million) Table 170. Latin America IVD Reagent Clinical Trial Services Market Share by Country (2021-2026) Table 171. Latin America IVD Reagent Clinical Trial Services Market Size Forecast by Country (2027-2032) & (US$ Million) Table 172. Latin America IVD Reagent Clinical Trial Services Market Share Forecast by Country (2027-2032) Table 173. Middle East & Africa IVD Reagent Clinical Trial Services Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 174. Middle East & Africa IVD Reagent Clinical Trial Services Market Size by Country (2021-2026) & (US$ Million) Table 175. Middle East & Africa IVD Reagent Clinical Trial Services Market Share by Country (2021-2026) Table 176. Middle East & Africa IVD Reagent Clinical Trial Services Market Size Forecast by Country (2027-2032) & (US$ Million) Table 177. Middle East & Africa IVD Reagent Clinical Trial Services Market Share Forecast by Country (2027-2032) Table 178. Research Programs/Design for This Report Table 179. Authors List of This Report Table 180. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. IVD Reagent Clinical Trial Services Product Image Figure 3. Global IVD Reagent Clinical Trial Services Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global IVD Reagent Clinical Trial Services Market Size (2021-2032) & (US$ Million) Figure 5. Global IVD Reagent Clinical Trial Services Market Share by Region: 2025 VS 2032 Figure 6. Global IVD Reagent Clinical Trial Services Market Share by Region (2021-2032) Figure 7. North America IVD Reagent Clinical Trial Services Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe IVD Reagent Clinical Trial Services Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific IVD Reagent Clinical Trial Services Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America IVD Reagent Clinical Trial Services Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa IVD Reagent Clinical Trial Services Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Early-Stage Clinical Trials (Phase I) Image Figure 13. Global Early-Stage Clinical Trials (Phase I) Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Late-Stage Clinical Trials (Phase III) Image Figure 15. Global Late-Stage Clinical Trials (Phase III) Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Global IVD Reagent Clinical Trial Services Market Size Overview by Type (2021-2032) & (US$ Million) Figure 17. Global IVD Reagent Clinical Trial Services Market Share by Type 2025 VS 2032 Figure 18. North America IVD Reagent Clinical Trial Services Market Size Share by Type (2021-2032) Figure 19. Europe IVD Reagent Clinical Trial Services Market Size Share by Type (2021-2032) Figure 20. Asia-Pacific IVD Reagent Clinical Trial Services Market Size Share by Type (2021-2032) Figure 21. Latin America IVD Reagent Clinical Trial Services Market Size Share by Type (2021-2032) Figure 22. Middle East and Africa IVD Reagent Clinical Trial Services Market Size Share by Type (2021-2032) Figure 23. Early Cancer Screening Image Figure 24. Global Early Cancer Screening Market Size YoY Growth (2021-2032) & (US$ Million) Figure 25. Infectious Disease Testing Image Figure 26. Global Infectious Disease Testing Market Size YoY Growth (2021-2032) & (US$ Million) Figure 27. Genetic Disease Diagnosis Image Figure 28. Global Genetic Disease Diagnosis Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. Other Image Figure 30. Global Other Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. Global IVD Reagent Clinical Trial Services Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global IVD Reagent Clinical Trial Services Market Share by Application 2025 VS 2032 Figure 33. North America IVD Reagent Clinical Trial Services Market Size Share by Application (2021-2032) Figure 34. Europe IVD Reagent Clinical Trial Services Market Size Share by Application (2021-2032) Figure 35. Asia-Pacific IVD Reagent Clinical Trial Services Market Size Share by Application (2021-2032) Figure 36. Latin America IVD Reagent Clinical Trial Services Market Size Share by Application (2021-2032) Figure 37. Middle East and Africa IVD Reagent Clinical Trial Services Market Size Share by Application (2021-2032) Figure 38. Global Top 5 and 10 IVD Reagent Clinical Trial Services Players Market Share by Revenue in 2025 Figure 39. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 40. North America IVD Reagent Clinical Trial Services Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 41. North America IVD Reagent Clinical Trial Services Market Share by Country: 2021 VS 2025 VS 2032 Figure 42. North America IVD Reagent Clinical Trial Services Market Share by Country (2021-2032) Figure 43. Europe IVD Reagent Clinical Trial Services Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. Europe IVD Reagent Clinical Trial Services Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe IVD Reagent Clinical Trial Services Market Share by Country (2021-2032) Figure 46. Asia-Pacific IVD Reagent Clinical Trial Services Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 47. Asia-Pacific IVD Reagent Clinical Trial Services Market Share by Country: 2021 VS 2025 VS 2032 Figure 48. Asia-Pacific IVD Reagent Clinical Trial Services Market Share by Country (2021-2032) Figure 49. Latin America IVD Reagent Clinical Trial Services Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Latin America IVD Reagent Clinical Trial Services Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America IVD Reagent Clinical Trial Services Market Share by Country (2021-2032) Figure 52. Middle East & Africa IVD Reagent Clinical Trial Services Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 53. Middle East & Africa IVD Reagent Clinical Trial Services Market Share by Country: 2021 VS 2025 VS 2032 Figure 54. Middle East & Africa IVD Reagent Clinical Trial Services Market Share by Country (2021-2032) Figure 55. Years Considered Figure 56. Research Process Figure 57. Key Executives Interviewed

Scope & coverage.

Types
  • Early-Stage Clinical Trials (Phase I)
  • Late-Stage Clinical Trials (Phase III)
Applications
  • Early Cancer Screening
  • Infectious Disease Testing
  • Genetic Disease Diagnosis
  • Other
Companies covered
  • IQVIA
  • ICON plc
  • Labcorp
  • NAMSA
  • Parexel
  • Medpace
  • Fortrea
  • Quest Diagnostics
  • Avania
  • Hangzhou Tigermed Consulting
  • Eurofins Scientific
  • Cerba Research
  • ClinChoice
  • CMIC Group
  • Syneos Health
  • ResearchDx
  • Premier Research
  • Quanticate
  • SGS
  • Guangzhou Jinmanli Pharmaceutical Technology
  • WuXi AppTec

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global IVD Reagent Clinical Trial Services Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global IVD Reagent Clinical Trial Services Market Size by Region (2021-2032)
  5. 1.4.1 Global IVD Reagent Clinical Trial Services Market Size by Region (2021-2026)
  6. 1.4.2 Global IVD Reagent Clinical Trial Services Market Size by Region (2027-2032)
  7. 1.5 Key Regions IVD Reagent Clinical Trial Services Market Size (2021-2032)
  8. 1.5.1 North America IVD Reagent Clinical Trial Services Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe IVD Reagent Clinical Trial Services Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific IVD Reagent Clinical Trial Services Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America IVD Reagent Clinical Trial Services Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa IVD Reagent Clinical Trial Services Market Size Growth Rate (2021-2032)
2 IVD Reagent Clinical Trial Services Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Early-Stage Clinical Trials (Phase I)
  3. 2.1.2 Late-Stage Clinical Trials (Phase III)
  4. 2.2 Global IVD Reagent Clinical Trial Services Market Size by Type
  5. 2.2.1 Global IVD Reagent Clinical Trial Services Market Size Overview by Type (2021-2032)
  6. 2.2.2 Global IVD Reagent Clinical Trial Services Historic Market Size Review by Type (2021-2026)
  7. 2.2.3 Global IVD Reagent Clinical Trial Services Market Size Forecasted by Type (2027-2032)
  8. 2.3 Global IVD Reagent Clinical Trial Services Market Size by Regions
  9. 2.3.1 North America IVD Reagent Clinical Trial Services Market Size Breakdown by Type (2021-2026)
  10. 2.3.2 Europe IVD Reagent Clinical Trial Services Market Size Breakdown by Type (2021-2026)
  11. 2.3.3 Asia-Pacific IVD Reagent Clinical Trial Services Market Size Breakdown by Type (2021-2026)
  12. 2.3.4 South America IVD Reagent Clinical Trial Services Market Size Breakdown by Type (2021-2026)
  13. 2.3.5 Middle East and Africa IVD Reagent Clinical Trial Services Market Size Breakdown by Type (2021-2026)
3 IVD Reagent Clinical Trial Services Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Early Cancer Screening
  3. 3.1.2 Infectious Disease Testing
  4. 3.1.3 Genetic Disease Diagnosis
  5. 3.1.4 Other
  6. 3.2 Global IVD Reagent Clinical Trial Services Market Size by Application
  7. 3.2.1 Global IVD Reagent Clinical Trial Services Market Size Overview by Application (2021-2032)
  8. 3.2.2 Global IVD Reagent Clinical Trial Services Historic Market Size Review by Application (2021-2026)
  9. 3.2.3 Global IVD Reagent Clinical Trial Services Market Size Forecasted by Application (2027-2032)
  10. 3.3 Global IVD Reagent Clinical Trial Services Market Size by Regions
  11. 3.3.1 North America IVD Reagent Clinical Trial Services Market Size Breakdown by Application (2021-2026)
  12. 3.3.2 Europe IVD Reagent Clinical Trial Services Market Size Breakdown by Application (2021-2026)
  13. 3.3.3 Asia-Pacific IVD Reagent Clinical Trial Services Market Size Breakdown by Application (2021-2026)
  14. 3.3.4 South America IVD Reagent Clinical Trial Services Market Size Breakdown by Application (2021-2026)
  15. 3.3.5 Middle East and Africa IVD Reagent Clinical Trial Services Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 IVD Reagent Clinical Trial Services Industry Trends
  2. 4.2 IVD Reagent Clinical Trial Services Industry Drivers
  3. 4.3 IVD Reagent Clinical Trial Services Industry Opportunities and Challenges
  4. 4.4 IVD Reagent Clinical Trial Services Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by IVD Reagent Clinical Trial Services Revenue (2021-2026)
  2. 5.2 Global IVD Reagent Clinical Trial Services Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global IVD Reagent Clinical Trial Services Key Company Headquarters & Area Served
  4. 5.4 Global IVD Reagent Clinical Trial Services Company, Product Type & Application
  5. 5.5 Global IVD Reagent Clinical Trial Services Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global IVD Reagent Clinical Trial Services Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 IVD Reagent Clinical Trial Services Players Market Share by Revenue in 2025
  9. 5.6.3 2025 IVD Reagent Clinical Trial Services Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 IQVIA
  2. 6.1.1 IQVIA Company Information
  3. 6.1.2 IQVIA Business Overview
  4. 6.1.3 IQVIA IVD Reagent Clinical Trial Services Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 IQVIA IVD Reagent Clinical Trial Services Product Portfolio
  6. 6.1.5 IQVIA Recent Developments
  7. 6.2 ICON plc
  8. 6.2.1 ICON plc Company Information
  9. 6.2.2 ICON plc Business Overview
  10. 6.2.3 ICON plc IVD Reagent Clinical Trial Services Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 ICON plc IVD Reagent Clinical Trial Services Product Portfolio
  12. 6.2.5 ICON plc Recent Developments
  13. 6.3 Labcorp
  14. 6.3.1 Labcorp Company Information
  15. 6.3.2 Labcorp Business Overview
  16. 6.3.3 Labcorp IVD Reagent Clinical Trial Services Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Labcorp IVD Reagent Clinical Trial Services Product Portfolio
  18. 6.3.5 Labcorp Recent Developments
  19. 6.4 NAMSA
  20. 6.4.1 NAMSA Company Information
  21. 6.4.2 NAMSA Business Overview
  22. 6.4.3 NAMSA IVD Reagent Clinical Trial Services Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 NAMSA IVD Reagent Clinical Trial Services Product Portfolio
  24. 6.4.5 NAMSA Recent Developments
  25. 6.5 Parexel
  26. 6.5.1 Parexel Company Information
  27. 6.5.2 Parexel Business Overview
  28. 6.5.3 Parexel IVD Reagent Clinical Trial Services Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Parexel IVD Reagent Clinical Trial Services Product Portfolio
  30. 6.5.5 Parexel Recent Developments
  31. 6.6 Medpace
  32. 6.6.1 Medpace Company Information
  33. 6.6.2 Medpace Business Overview
  34. 6.6.3 Medpace IVD Reagent Clinical Trial Services Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Medpace IVD Reagent Clinical Trial Services Product Portfolio
  36. 6.6.5 Medpace Recent Developments
  37. 6.7 Fortrea
  38. 6.7.1 Fortrea Company Information
  39. 6.7.2 Fortrea Business Overview
  40. 6.7.3 Fortrea IVD Reagent Clinical Trial Services Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 Fortrea IVD Reagent Clinical Trial Services Product Portfolio
  42. 6.7.5 Fortrea Recent Developments
  43. 6.8 Quest Diagnostics
  44. 6.8.1 Quest Diagnostics Company Information
  45. 6.8.2 Quest Diagnostics Business Overview
  46. 6.8.3 Quest Diagnostics IVD Reagent Clinical Trial Services Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Quest Diagnostics IVD Reagent Clinical Trial Services Product Portfolio
  48. 6.8.5 Quest Diagnostics Recent Developments
  49. 6.9 Avania
  50. 6.9.1 Avania Company Information
  51. 6.9.2 Avania Business Overview
  52. 6.9.3 Avania IVD Reagent Clinical Trial Services Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 Avania IVD Reagent Clinical Trial Services Product Portfolio
  54. 6.9.5 Avania Recent Developments
  55. 6.10 Hangzhou Tigermed Consulting
  56. 6.10.1 Hangzhou Tigermed Consulting Company Information
  57. 6.10.2 Hangzhou Tigermed Consulting Business Overview
  58. 6.10.3 Hangzhou Tigermed Consulting IVD Reagent Clinical Trial Services Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 Hangzhou Tigermed Consulting IVD Reagent Clinical Trial Services Product Portfolio
  60. 6.10.5 Hangzhou Tigermed Consulting Recent Developments
  61. 6.11 Eurofins Scientific
  62. 6.11.1 Eurofins Scientific Company Information
  63. 6.11.2 Eurofins Scientific Business Overview
  64. 6.11.3 Eurofins Scientific IVD Reagent Clinical Trial Services Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 Eurofins Scientific IVD Reagent Clinical Trial Services Product Portfolio
  66. 6.11.5 Eurofins Scientific Recent Developments
  67. 6.12 Cerba Research
  68. 6.12.1 Cerba Research Company Information
  69. 6.12.2 Cerba Research Business Overview
  70. 6.12.3 Cerba Research IVD Reagent Clinical Trial Services Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 Cerba Research IVD Reagent Clinical Trial Services Product Portfolio
  72. 6.12.5 Cerba Research Recent Developments
  73. 6.13 ClinChoice
  74. 6.13.1 ClinChoice Company Information
  75. 6.13.2 ClinChoice Business Overview
  76. 6.13.3 ClinChoice IVD Reagent Clinical Trial Services Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 ClinChoice IVD Reagent Clinical Trial Services Product Portfolio
  78. 6.13.5 ClinChoice Recent Developments
  79. 6.14 CMIC Group
  80. 6.14.1 CMIC Group Company Information
  81. 6.14.2 CMIC Group Business Overview
  82. 6.14.3 CMIC Group IVD Reagent Clinical Trial Services Revenue, Global Share and Gross Margin (2021-2026)
  83. 6.14.4 CMIC Group IVD Reagent Clinical Trial Services Product Portfolio
  84. 6.14.5 CMIC Group Recent Developments
  85. 6.15 Syneos Health
  86. 6.15.1 Syneos Health Company Information
  87. 6.15.2 Syneos Health Business Overview
  88. 6.15.3 Syneos Health IVD Reagent Clinical Trial Services Revenue, Global Share and Gross Margin (2021-2026)
  89. 6.15.4 Syneos Health IVD Reagent Clinical Trial Services Product Portfolio
  90. 6.15.5 Syneos Health Recent Developments
  91. 6.16 ResearchDx
  92. 6.16.1 ResearchDx Company Information
  93. 6.16.2 ResearchDx Business Overview
  94. 6.16.3 ResearchDx IVD Reagent Clinical Trial Services Revenue, Global Share and Gross Margin (2021-2026)
  95. 6.16.4 ResearchDx IVD Reagent Clinical Trial Services Product Portfolio
  96. 6.16.5 ResearchDx Recent Developments
  97. 6.17 Premier Research
  98. 6.17.1 Premier Research Company Information
  99. 6.17.2 Premier Research Business Overview
  100. 6.17.3 Premier Research IVD Reagent Clinical Trial Services Revenue, Global Share and Gross Margin (2021-2026)
  101. 6.17.4 Premier Research IVD Reagent Clinical Trial Services Product Portfolio
  102. 6.17.5 Premier Research Recent Developments
  103. 6.18 Quanticate
  104. 6.18.1 Quanticate Company Information
  105. 6.18.2 Quanticate Business Overview
  106. 6.18.3 Quanticate IVD Reagent Clinical Trial Services Revenue, Global Share and Gross Margin (2021-2026)
  107. 6.18.4 Quanticate IVD Reagent Clinical Trial Services Product Portfolio
  108. 6.18.5 Quanticate Recent Developments
  109. 6.19 SGS
  110. 6.19.1 SGS Company Information
  111. 6.19.2 SGS Business Overview
  112. 6.19.3 SGS IVD Reagent Clinical Trial Services Revenue, Global Share and Gross Margin (2021-2026)
  113. 6.19.4 SGS IVD Reagent Clinical Trial Services Product Portfolio
  114. 6.19.5 SGS Recent Developments
  115. 6.20 Guangzhou Jinmanli Pharmaceutical Technology
  116. 6.20.1 Guangzhou Jinmanli Pharmaceutical Technology Company Information
  117. 6.20.2 Guangzhou Jinmanli Pharmaceutical Technology Business Overview
  118. 6.20.3 Guangzhou Jinmanli Pharmaceutical Technology IVD Reagent Clinical Trial Services Revenue, Global Share and Gross Margin (2021-2026)
  119. 6.20.4 Guangzhou Jinmanli Pharmaceutical Technology IVD Reagent Clinical Trial Services Product Portfolio
  120. 6.20.5 Guangzhou Jinmanli Pharmaceutical Technology Recent Developments
  121. 6.21 WuXi AppTec
  122. 6.21.1 WuXi AppTec Company Information
  123. 6.21.2 WuXi AppTec Business Overview
  124. 6.21.3 WuXi AppTec IVD Reagent Clinical Trial Services Revenue, Global Share and Gross Margin (2021-2026)
  125. 6.21.4 WuXi AppTec IVD Reagent Clinical Trial Services Product Portfolio
  126. 6.21.5 WuXi AppTec Recent Developments
7 North America
  1. 7.1 North America IVD Reagent Clinical Trial Services Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America IVD Reagent Clinical Trial Services Market Size by Country (2021-2026)
  3. 7.3 North America IVD Reagent Clinical Trial Services Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe IVD Reagent Clinical Trial Services Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe IVD Reagent Clinical Trial Services Market Size by Country (2021-2026)
  3. 8.3 Europe IVD Reagent Clinical Trial Services Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific IVD Reagent Clinical Trial Services Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific IVD Reagent Clinical Trial Services Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific IVD Reagent Clinical Trial Services Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America IVD Reagent Clinical Trial Services Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America IVD Reagent Clinical Trial Services Market Size by Country (2021-2026)
  3. 10.3 South America IVD Reagent Clinical Trial Services Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa IVD Reagent Clinical Trial Services Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa IVD Reagent Clinical Trial Services Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa IVD Reagent Clinical Trial Services Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst